Skip to content
Menu

Adaptimmune Therapeutics plc ADAPY

Full chart Compare
Set alert

Price alert · ADAPY

All alert types
0.03 USD +0.01 (+27.66%)

As ofNov 19, 2026, 3:50 PM EST

0.029 Day range 0.0325
0.001 52-week range 0.07
YTD
+15.38%
1 year
-50.82%

Revenue & Expenses

Revenue Profit Costs
Other Income$97.78MOther Operating Income$5.12MGross Profit$5.92MGross Profit & Other Income$108.82MNet Income$25.21MSelling, General & Admin$35.62MResearch & Development$47.99MRevenue$5.92M

Latest period ending Dec 31, 2024 · select a line to chart its full history

ADAPY annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
178.03M60.28M27.15M6.15M3.96M
177.96M60.28M27.15M6.15M3.96M
-68.76M-139.74M-163.97M-162.25M-133.41M
-70.81M-113.87M-165.46M-158.09M-130.09M
-0.30-0.54-1.02-1.02-0.90
ADAPY annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
93.21M147.02M109.60M151.67M61.48M
245.96M282.62M328.92M469.55M451.14M
234.11M243.10M247.04M263.58M109.92M
74.21M25.23M23.08M25.47M23.71M
11.85M39.51M81.88M205.96M341.23M
ADAPY annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-73.21M-140.88M-141.77M10.73M-53.59M
-58.95M176.54M89.14M75.80M-278.92M
78.75M880.00K12.87M3.29M340.05M
-886.00K-4.68M-29.50M-8.57M-2.34M
-53.81M37.41M-42.06M90.18M6.58M